This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Data pager
Data pager
12
 Item 1 to 99 of 150
of 2 
Show all 150
Data pager
Data pager
12
 Item 1 to 99 of 150
of 2 
Show all 150
Sunday, February 11 | 4:00PM - 8:00PM
Arrival and Registration
Room: Longs Peak Foyer


Sunday, February 11 | 6:00PM - 8:00PM
Welcome Mixer
Room: Longs Peak Foyer
No registration fees are used to fund alcohol served at this function.

Monday, February 12 | 7:00AM - 8:00AM
Breakfast
Room: Colorado Rockies Ballroom


Monday, February 12 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Quandary Peak

Speaker 1 of 2
* Iannis Aifantis, New York University School of Medicine, USA

Monday, February 12 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Quandary Peak

Speaker 2 of 2
Alexander Y. Rudensky, HHMI/Memorial Sloan Kettering Cancer Center, USA
Regulatory T Cells and their Functions in the Tumor Microenvironment

Monday, February 12 | 9:00AM - 11:15AM
Understanding Lymphocytic Malignancy: Leukemia and Lymphoma
Room: Quandary Peak

Speaker 1 of 6
* Adolfo Ferrando, Columbia University, USA

Monday, February 12 | 9:00AM - 11:15AM
Understanding Lymphocytic Malignancy: Leukemia and Lymphoma
Room: Quandary Peak

Speaker 2 of 6
Louis M. Staudt, NCI, National Institutes of Health, USA
The MYD88-TLR9-B Cell Receptor Complex as a Target for Therapy in Aggressive Lymphomas


Monday, February 12 | 9:00AM - 11:15AM
Understanding Lymphocytic Malignancy: Leukemia and Lymphoma
Room: Quandary Peak


Coffee Break

Monday, February 12 | 9:00AM - 11:15AM
Understanding Lymphocytic Malignancy: Leukemia and Lymphoma
Room: Quandary Peak

Speaker 4 of 6
Charles G. Mullighan, St. Jude Children's Research Hospital, USA
The Role of CREBBP Mutations in Drug Resistance in Acute Lymphoblastic Leukemia

Monday, February 12 | 9:00AM - 11:15AM
Understanding Lymphocytic Malignancy: Leukemia and Lymphoma
Room: Quandary Peak

Speaker 5 of 6
Katia Georgopoulos, Massachusetts General Hospital, USA
Super-Enhancer Circuits in B Cell Development and Transformation

Monday, February 12 | 9:00AM - 11:15AM
Understanding Lymphocytic Malignancy: Leukemia and Lymphoma
Room: Quandary Peak

Speaker 6 of 6
Anastasia N. Tikhonova, New York University Medical School, USA
Short Talk: Single-Cell Dynamics of Bone Marrow Microenvironment

Monday, February 12 | 9:00AM - 11:30AM
CAR/TCR Preclinical
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 1 of 7
* Carl H. June, University of Pennsylvania, USA


Monday, February 12 | 9:00AM - 11:30AM
CAR/TCR Preclinical
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 2 of 7
Philip D. Greenberg, University of Washington, USA
Making TCR-Modified T Cells Effective for Leukemia and Solid Tumors


Monday, February 12 | 9:00AM - 11:30AM
CAR/TCR Preclinical
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak


Coffee Break


Monday, February 12 | 9:00AM - 11:30AM
CAR/TCR Preclinical
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 4 of 7
Crystal L. Mackall, Stanford University, USA
What’s Next? Preclinical Studies Paving the Way for Future CAR T Cell Trials


Monday, February 12 | 9:00AM - 11:30AM
CAR/TCR Preclinical
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 5 of 7
Stanley R. Riddell, Fred Hutchinson Cancer Research Center, University of Washington, USA
Strategies to Improve the Efficacy of CAR T Cells in Solid Tumors


Monday, February 12 | 9:00AM - 11:30AM
CAR/TCR Preclinical
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 6 of 7
Reno Debets, Erasmus MC Cancer Institute, Netherlands
Short Talk: T Cell Receptors Equipped with ICOS Enhance T Cell Persistence and Mediate Sustainable Anti-Tumor Responses upon Adoptive T Cell Therapy


Monday, February 12 | 9:00AM - 11:30AM
CAR/TCR Preclinical
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 7 of 7
James Scott-Browne, La Jolla Institute, USA
Short Talk: Transcriptional Control of CAR-T Cell Function in Solid Tumors


Monday, February 12 | 11:15AM - 5:00PM
On Own for Lunch


Monday, February 12 | 11:15AM - 1:00PM
Poster Setup
Room: Colorado Rockies Ballroom


Monday, February 12 | 1:00PM - 10:00PM
Poster Viewing
Room: Colorado Rockies Ballroom


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 1 of 9
* Iannis Aifantis, New York University School of Medicine, USA

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 2 of 9
Eirini Giannakopoulou, Radiumhospitalet, Norway
T Cell Receptor-Mediated Targeting of Recurrent Neoantigens in Acute Myeloid Leukemia

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 3 of 9
Wenting Zheng, St. Jude Children Research Hospital, USA
PI3K Orchestration of the in vivo Persistence of Chimeric Antigen Receptor-Modified T Cells

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 4 of 9
Elena Montauti, Northwestern University, USA
USP22 Maintains Regulatory T Cells by Stabilizing Foxp3 Protein Level and Impairs Anti-Tumor Immune Response

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 5 of 9
Jeffrey Ward, Washington University School of Medicine, USA
Remodeling of Myeloid as well as Lymphoid Compartments following Checkpoint Blockade Immunotherapy

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 6 of 9
Soki Kashima, Kyoto University, Japan
WT1-Specific Cytotoxic T Lymphocytes Regenerated from T Cell-Derived iPS Cells Exert Therapeutic Effect in Xenograft Model of Renal Cell Carcinoma

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 7 of 9
Chris Nicolai, University of California, Berkeley, USA
Mechanisms of MHC-Deficient Tumor Clearance using STING Agonists

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 8 of 9
Julie Rytlewski, Bristol-Myers Squibb, USA
History of Prior Immunotherapy Changes Relationship between Tumor Mutations and TIL Repertoire

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Understanding and Targeting Lymphocytes in Cance
r
Room: Quandary Peak

Speaker 9 of 9
Angela Vasaturo, INSERM UMRS 1138, France
Unraveling the Immune Contexture of Pre-Invasive Lesions of the Lung by Multispectral Imaging

Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 1 of 9
* Charles Sentman, Geisel School of Medicine at Dartmouth, USA


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 2 of 9
Amy Gilbert, Cell Design Labs, USA
Development of a SynNotch Combinatorial “and” Gate CAR T for Solid Tumors


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 3 of 9
Ian R. Hardy, TCR2 Therapeutics, USA
Improving CAR-T Cell Function with Small Molecule Treatment during Production


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 4 of 9
Kelan Hlavaty, SQZ Biotech, USA
Engineering T Cells Using a Microfluidic Intracellular Delivery Method for Cell Therapy


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 5 of 9
Robert J. Hofmeister, TCR2 Therapeutics, USA
A Novel T Cell Therapy Engaging the Complete T Cell Receptor


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 6 of 9
Lenka V. Hurton, ZIOPHARM Oncology, USA
Rapid Production of T Cells Co-expressing CAR and Membrane-bound IL-15 Potentiates Antitumor Activity and Promotes in vivo Memory


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 7 of 9
Sumiti Jain, Sangamo Therapeutics, USA
Precise T Cell Engineering using Enhanced Zinc-finger Nucleases (ZFNs) for Highly Specific and Efficient Dual Knock-Out of Endogenous T-Cell Receptor and HLA-Class I with Site-Specific Insertion of a CD19-CAR: Implications for Allogeneic T Cell Therapy


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 8 of 9
Inez Johanna, University Medical Center Utrecht, Netherlands
Towards the Next Generation CAR T Cells with TEGs: In vivo Efficacy – Toxicity Profile in Xenografts of Primary Human AML Disease and Healthy Bone Marrow


Monday, February 12 | 2:30PM - 4:30PM
Workshop 1: Perspectives from Industry
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 9 of 9
Levi Rupp, Cell Design Labs, USA
THROTTLETM CARs: A Novel Platform for Enhanced Safety and Efficacy via Titratable Control of CAR-T Activity using an FDA-Approved Small Molecule


Monday, February 12 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Monday, February 12 | 5:00PM - 7:00PM
Therapeutic Targeting of Lymphocytic Malignancy
Room: Quandary Peak

Speaker 1 of 5
* Charles G. Mullighan, St. Jude Children's Research Hospital, USA

Monday, February 12 | 5:00PM - 7:00PM
Therapeutic Targeting of Lymphocytic Malignancy
Room: Quandary Peak

Speaker 2 of 5
Adolfo Ferrando, Columbia University, USA
Epigenetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia

Monday, February 12 | 5:00PM - 7:00PM
Therapeutic Targeting of Lymphocytic Malignancy
Room: Quandary Peak

Speaker 3 of 5
Iannis Aifantis, New York University School of Medicine, USA
Targeting Stress Responses in Acute Lymphocytic Leukemia

Monday, February 12 | 5:00PM - 7:00PM
Therapeutic Targeting of Lymphocytic Malignancy
Room: Quandary Peak

Speaker 4 of 5
Andrei Thomas-Tikhonenko, Children's Hospital of Philadelphia and University of Pennsylvania, USA
Escape Hatches for Immunotherapies Targeting B-Cell Differentiation Antigens

Monday, February 12 | 5:00PM - 7:00PM
Therapeutic Targeting of Lymphocytic Malignancy
Room: Quandary Peak

Speaker 5 of 5
Jacques G. M. Ghysdael, Institut Curie, France
Short Talk: Triggering the Tcr Developmental Checkpoint Activates a Therapeutically Targetable Anti-Leukemic Pathway in T-Cell Acute Lymphoblastic Leukemia

Monday, February 12 | 5:00PM - 7:00PM
Synthetic Biology
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 1 of 5
* Crystal L. Mackall, Stanford University, USA


Monday, February 12 | 5:00PM - 7:00PM
Synthetic Biology
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 2 of 5
Darrell J. Irvine, Massachusetts Institute of Technology, USA
Chemically Engineering T Cell Therapies


Monday, February 12 | 5:00PM - 7:00PM
Synthetic Biology
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 3 of 5
Wendell A. Lim, University of California, San Francisco, USA
Optimizing Synthetic Biology Tools for T Cell Therapies


Monday, February 12 | 5:00PM - 7:00PM
Synthetic Biology
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 4 of 5
Travis Young, California Institute for Biomedical Research, USA
Controllable CAR-T Cell Therapy


Monday, February 12 | 5:00PM - 7:00PM
Synthetic Biology
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 5 of 5
Patrick Ho, University of California, Los Angeles, USA
Short Talk: COVERT T Cells: Engineering T Cells to Interrogate Intracellular Antigens


Monday, February 12 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Monday, February 12 | 7:30PM - 10:00PM
Poster Session 1
Room: Colorado Rockies Ballroom


Tuesday, February 13 | 7:00AM - 8:00AM
Breakfast
Room: Colorado Rockies Ballroom


Tuesday, February 13 | 8:00AM - 11:00AM
Cellular Therapies in Blood Malignancies and Beyond
Room: Quandary Peak

Speaker 1 of 7
* Ugur Sahin, BioNTech AG, Germany

Tuesday, February 13 | 8:00AM - 11:00AM
Cellular Therapies in Blood Malignancies and Beyond
Room: Quandary Peak

Speaker 2 of 7
Carl H. June, University of Pennsylvania, USA
CAR T Cells and their Therapeutic Promise in the Treatment of Leukemia

Tuesday, February 13 | 8:00AM - 11:00AM
Cellular Therapies in Blood Malignancies and Beyond
Room: Quandary Peak

Speaker 3 of 7
Crystal L. Mackall, Stanford University, USA
CAR Vulnerabilities: Emerging Insights from Clinical Trials

Tuesday, February 13 | 8:00AM - 11:00AM
Cellular Therapies in Blood Malignancies and Beyond
Room: Quandary Peak


Coffee Break

Tuesday, February 13 | 8:00AM - 11:00AM
Cellular Therapies in Blood Malignancies and Beyond
Room: Quandary Peak

Speaker 5 of 7
Chiara Bonini, Ospedale San Raffaele, Italy
Gene Editing of Memory Stem T Cells for Cancer Immunotherapy

Tuesday, February 13 | 8:00AM - 11:00AM
Cellular Therapies in Blood Malignancies and Beyond
Room: Quandary Peak

Speaker 6 of 7
Justin Eyquem, University of California, San Francisco, USA
Precision T Cell Engineering to Advance Adoptive T Cell Therapies

Tuesday, February 13 | 8:00AM - 11:00AM
Cellular Therapies in Blood Malignancies and Beyond
Room: Quandary Peak

Speaker 7 of 7
Charlotte Mousset, Radboudumc, Netherlands
Short Talk: Superior Multi-Functionality and Glycolytic Function of Tumor-Reactive CD8+ TSCM-Like T Cells by ex vivo Akt-Inhibition

Tuesday, February 13 | 8:00AM - 11:00AM
Engineered T Cells for Viruses
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 1 of 7
* Philip D. Greenberg, University of Washington, USA


Tuesday, February 13 | 8:00AM - 11:00AM
Engineered T Cells for Viruses
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 2 of 7
Catherine M. Bollard, Children’s National Health System, USA
Developing HIV-Specific T Cell Therapies: Lessons from EBV


Tuesday, February 13 | 8:00AM - 11:00AM
Engineered T Cells for Viruses
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 3 of 7
Paula M. Cannon, University of Southern California, Keck School of Medicine, USA
Shutting the Door on HIV by Engineering Hematopoietic Stem Cells


Tuesday, February 13 | 8:00AM - 11:00AM
Engineered T Cells for Viruses
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak


Coffee Break


Tuesday, February 13 | 8:00AM - 11:00AM
Engineered T Cells for Viruses
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 5 of 7
James L. Riley, University of Pennsylvania, USA
Engineering T Cells to Functionally Cure HIV-1 Infection


Tuesday, February 13 | 8:00AM - 11:00AM
Engineered T Cells for Viruses
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 6 of 7
Scott G. Kitchen, University of California, Los Angeles AIDS Institute, USA
Engineering Antiviral CAR T Cell Immunity through Hematopoietic Stem/Progenitor Cells


Tuesday, February 13 | 8:00AM - 11:00AM
Engineered T Cells for Viruses
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 7 of 7
Alok Vishnu Joglekar, California Institute of Technology, USA
Short Talk: Hematopoietic Stem/Progenitor Cells Engineered with T Cell Receptors for Immunotherapy for HIV Infection


Tuesday, February 13 | 11:00AM - 5:00PM
On Own for Lunch


Tuesday, February 13 | 11:00AM - 1:00PM
Poster Setup
Room: Colorado Rockies Ballroom


Tuesday, February 13 | 1:00PM - 10:00PM
Poster Viewing
Room: Colorado Rockies Ballroom


Tuesday, February 13 | 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer


Tuesday, February 13 | 5:00PM - 7:00PM
Lymphocytes as Elements of the Tumor Microenvironment
Room: Quandary Peak

Speaker 1 of 5
* Katia Georgopoulos, Massachusetts General Hospital, USA

Tuesday, February 13 | 5:00PM - 7:00PM
Lymphocytes as Elements of the Tumor Microenvironment
Room: Quandary Peak

Speaker 2 of 5
David H. Raulet, University of California, Berkeley, USA
Natural Killer Cell Activation and Inhibition: Potential for Cancer Therapy

Tuesday, February 13 | 5:00PM - 7:00PM
Lymphocytes as Elements of the Tumor Microenvironment
Room: Quandary Peak

Speaker 3 of 5
Michael Khodadoust, Stanford University, USA
T Cell Recognition of Lymphoma Immunoglobulin

Tuesday, February 13 | 5:00PM - 7:00PM
Lymphocytes as Elements of the Tumor Microenvironment
Room: Quandary Peak

Speaker 4 of 5
Mikala Egeblad, Cold Spring Harbor Laboratory, USA
Visualization of the Switch from Immune Control to Immune Escape

Tuesday, February 13 | 5:00PM - 7:00PM
Lymphocytes as Elements of the Tumor Microenvironment
Room: Quandary Peak

Speaker 5 of 5
Annelise Snyder, University of Washington, USA
Short Talk: Anti-tumor Effects of Inflammatory Necroptosis Within the Tumor Microenvironment

Tuesday, February 13 | 5:00PM - 7:00PM
CAR/TCR in the Clinic for Cancer
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 1 of 5
* Jeffrey S. Miller, University of Minnesota, USA


Tuesday, February 13 | 5:00PM - 7:00PM
CAR/TCR in the Clinic for Cancer
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 2 of 5
Stephen J. Forman, City of Hope, USA
CAR T Cells for Treatment of Central Nervous System (CNS) Malignancy


Tuesday, February 13 | 5:00PM - 7:00PM
CAR/TCR in the Clinic for Cancer
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 3 of 5
Marcela V. Maus, Harvard Medical School, USA
CAR T Cells Multiple Myeloma and Glioblastoma


Tuesday, February 13 | 5:00PM - 7:00PM
CAR/TCR in the Clinic for Cancer
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 4 of 5
Saar I. Gill, University of Pennsylvania, USA
CAR T Cells for Acute Myelogenous Leukemia


Tuesday, February 13 | 5:00PM - 7:00PM
CAR/TCR in the Clinic for Cancer
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 5 of 5
Jenessa Barbara Smith, Poseida Therapeutics, USA
Short Talk: PSMA-Specific CAR T-Stem Cell Memory Therapy Eliminates Solid Tumor in Prostate Cancer Model


Tuesday, February 13 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Tuesday, February 13 | 7:30PM - 10:00PM
Poster Session 2
Room: Colorado Rockies Ballroom


Wednesday, February 14 | 7:00AM - 8:00AM
Breakfast
Room: Colorado Rockies Ballroom


Wednesday, February 14 | 8:00AM - 11:00AM
Emerging Technologies: Visualization and Dissection of the T
umor Microenvironment

Room: Quandary Peak

Speaker 1 of 6
* Mikala Egeblad, Cold Spring Harbor Laboratory, USA

Wednesday, February 14 | 8:00AM - 11:00AM
Emerging Technologies: Visualization and Dissection of the T
umor Microenvironment

Room: Quandary Peak

Speaker 2 of 6
Dana Pe'er, Memorial Sloan Kettering Cancer Center, USA
A Single Cell Approach to Understanding the Tumor Microenvironment

Wednesday, February 14 | 8:00AM - 11:00AM
Emerging Technologies: Visualization and Dissection of the T
umor Microenvironment

Room: Quandary Peak

Speaker 3 of 6
Matthew F. Krummel, University of California, San Francisco, USA
Imaging a World beyond Checkpoints: Innate Partners for Lymphocytes in Cancer


Wednesday, February 14 | 8:00AM - 11:00AM
Emerging Technologies: Visualization and Dissection of the T
umor Microenvironment

Room: Quandary Peak


Coffee Break

Wednesday, February 14 | 8:00AM - 11:00AM
Emerging Technologies: Visualization and Dissection of the T
umor Microenvironment

Room: Quandary Peak

Speaker 5 of 6
Jerome Galon, INSERM UMRS1138, Cordeliers Research Center, France
Immunoscore as a Stronger Predictor of Patient Survival in Colorectal Cancer

Wednesday, February 14 | 8:00AM - 11:00AM
Emerging Technologies: Visualization and Dissection of the T
umor Microenvironment

Room: Quandary Peak

Speaker 6 of 6
Michael Goldberg, Dana-Farber Cancer Institute, USA
Enhancing Cancer Immunotherapy through Immuno-engineering

Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 1 of 8
* James L. Riley, University of Pennsylvania, USA


Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 2 of 8
Bruce R. Blazar, University of Minnesota, USA
Vimentin Restrains Regulatory T-cell Suppression of Graft-versus-Host Disease


Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 3 of 8
Jeffrey A. Bluestone, University of California, San Francisco, USA
Manipulating Tregs to Control Tolerance in Autoimmunity and Cancer


Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak


Coffee Break


Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 5 of 8
Megan K. Levings, University of British Columbia, Canada
HLA-A2 Directed CAR Tregs


Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 6 of 8
David Klatzmann, Sorbonne University Medical School, France
IL-2 for Treg-Based Immunotherapies: In (and Out)


Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 7 of 8
Angela C. Boroughs, Massachusetts General Hospital/Harvard University, USA
Short Talk: 4-1BB Co-Stimulation Inhibits CAR Treg Suppressive Function


Wednesday, February 14 | 8:00AM - 11:15AM
Tregs as Cellular Therapeutics
This session is from Emerging Cellular Therapies
Room: Grays/Longs Peak

Speaker 8 of 8
Elmar Jaeckel, Hannover Medical School, Germany
Short Talk: Operational Tolerance in Allotransplantation by Use of Regulatory T Cells with a MHC-Specific Chimeric Antigen Receptor


Wednesday, February 14 | 11:15AM - 5:00PM
On Own for Lunch


No content found

No content found

No content found